LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.018333
 37.71 27.76 2354 2877 0.8180 0.9409
MN20160318_Q01
C22
MCF 10A-H2B-mCherry Dasatinib
0.018333
 37.71 27.76 196 2877 0.0681 0.3390
MN20160318_Q01
G16
MCF 10A-H2B-mCherry Dasatinib
0.018333
 37.71 27.76 2689 2877 0.9345 0.9799
MN20160318_Q01
G16
MCF 10A-H2B-mCherry Dasatinib
0.018333
 39.41 27.76 9 3105 0.0029 -0.1525
MN20160318_Q01
C22
MCF 10A-H2B-mCherry Dasatinib
0.018333
 39.41 27.76 2782 3105 0.8958 0.9679
MN20160318_Q01
C22
MCF 10A-H2B-mCherry Dasatinib
0.018333
 39.41 27.76 232 3105 0.0747 0.3661
MN20160318_Q01
G16
MCF 10A-H2B-mCherry Dasatinib
0.018333
 39.41 27.76 2824 3105 0.9093 0.9723
MN20160318_Q01
G16
MCF 10A-H2B-mCherry Dasatinib
0.018333
 41.11 27.76 9 3331 0.0027 -0.1505
MN20160318_Q01
C22
MCF 10A-H2B-mCherry Dasatinib
0.018333
 41.11 27.76 3145 3331 0.9440 0.9834
MN20160318_Q01
C22
MCF 10A-H2B-mCherry Dasatinib
0.018333
 41.11 27.76 263 3331 0.0789 0.3848
MN20160318_Q01
G16
MCF 10A-H2B-mCherry Dasatinib
0.018333
 41.11 27.76 3018 3331 0.9059 0.9716
MN20160318_Q01
G16
MCF 10A-H2B-mCherry Dasatinib
0.018333
 42.81 27.76 9 3596 0.0025 -0.1483
MN20160318_Q01
C22
MCF 10A-H2B-mCherry Dasatinib
0.018333
 42.81 27.76 3362 3596 0.9349 0.9809
MN20160318_Q01
C22
MCF 10A-H2B-mCherry Dasatinib
0.018333
 42.81 27.76 297 3596 0.0826 0.4018
MN20160318_Q01
G16
MCF 10A-H2B-mCherry Dasatinib
0.018333
 42.81 27.76 3261 3596 0.9068 0.9723
MN20160318_Q01
G16
MCF 10A-H2B-mCherry Dasatinib
0.018333
 44.52 27.76 10 3884 0.0026 -0.1334
MN20160318_Q01
C22
MCF 10A-H2B-mCherry Dasatinib
0.018333
 44.52 27.76 3546 3884 0.9129 0.9746
MN20160318_Q01
C22
MCF 10A-H2B-mCherry Dasatinib
0.018333
 44.52 27.76 319 3884 0.0821 0.4085
MN20160318_Q01
G16
MCF 10A-H2B-mCherry Dasatinib
0.018333
 44.52 27.76 3461 3884 0.8910 0.9679
MN20160318_Q01
G16
MCF 10A-H2B-mCherry Dasatinib
0.018333
 46.22 27.76 9 4125 0.0022 -0.1445
MN20160318_Q01
C22
MCF 10A-H2B-mCherry Dasatinib
0.018333
 46.22 27.76 3739 4125 0.9064 0.9730
MN20160318_Q01
C22
MCF 10A-H2B-mCherry Dasatinib
0.018333
 46.22 27.76 337 4125 0.0817 0.4134
MN20160318_Q01
G16
MCF 10A-H2B-mCherry Dasatinib
0.018333
 46.22 27.76 3757 4125 0.9108 0.9743
MN20160318_Q01
G16
MCF 10A-H2B-mCherry Dasatinib
0.018333
 47.93 27.76 9 4421 0.0020 -0.1427
MN20160318_Q01
C22
MCF 10A-H2B-mCherry Dasatinib
0.018333
 47.93 27.76 3955 4421 0.8945 0.9698
MN20160318_Q01
C22